Innovation drivers and access to risk capital
Partnership for Life is a meeting where global industry representatives meet biotech and academia. We will discuss the future pipeline and hear from world leading companies what valuable innovation look like. The session will also cover the access to competence and risk capital within life sciences after the Covid- 19 pandemic followed by geopolitical instability, increasing inflation and falling stock market.
11:00-12:30
Future pipeline and what does valuable innovation look like?
Intro to topic with Sergio Capancioni and Monica Larsen
A dialogue with:
- Sergio Capancioni, Director search and evaluation, Abbvie
- Jonas Einarsson, Oslo Cancer Cluster/Radforsk
- Sue Bailey, Senior Director, Geographic Search, Europe Search Lead, Bristol Myers Squibb
- Trond Methi, Medical director, Novo Nordisk
-
Anders Persson, Executive Director for Ecosystem Strategy & Innovation, AstraZeneca
Moderator: Monica Larsen, Senior Advisor, LMI
Photo: J. Einarsson: Radforsk
Access to competence and risk capital post Covid
Intro to topic by Gert Munthe, Founding Partner and Chairman, Herkules Capital
A dialogue with:
- Øyvind Enger, The Life Science Cluster/Partner, Investment Advisor, Sarsia Seed
- Ingrid Teigland Akay, Managing Partner, Hadean Ventures
- Sebastian Intveen, Director, DNB markets
- Allon Groth, Chief Communications and Marketing Officer, Eksfin
Moderator: Jan Erik Fåne, Executive Director Communications, Finance Norway
All day event
Partnership for Life - Matchmaking Meetings
One-to-one matchmaking meetings which aims to match companies and investors with academic research groups and start-ups.
To participate, you need to create a personal profile in Brella. How to create your personal profile
Registration
The conference is fully booked, the registration is closed.
